The developmental regulation of wake/sleep system

Neuroendocrine Correlates of Sleep/Wakefulness

Volumn , Issue , 2006, Pages 3-18

  Feng, Pingfu ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646486985     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-23692-9_1     Document Type: Chapter

References (105)

1. Jouvet-Mounier D, Astic L, Lacote D. Ontogenesis of the states of sleep in rat, cat, and guinea pig during the first postnatal month. Dev Psychobiol 1970;2:216-39.
2. McGinty DJ, Stevenson M, Hoppenbrouwers T et al. Polygraphic studies of kitten development: sleep state patterns. Dev Psychobiol 1977;10:455-69.
3. Feng P, Ma Y. Clomipramine suppresses postnatal REM sleep without increasing wakefulness: implications for the production of depressive behaviors. Sleep 2002;25:177-84.
4. Komissarov IV, Talalaenko AN. Nature of the central adreno- and serotonin-sensitive structures participating in the facilitating influence of bioamines on the respiratory reflex from the upper respiratory passages. Biull Eksp Biol Med 1970;70:52-5.
5. Vogel GW, Feng P, Kinney GG. Ontogeny of REM sleep in rats: possible implications for endogenous depression. Physiol Behav 2000;68:453-61.
6. Feng P, Ma Y, Vogel GW. The critical window of brain development from susceptive to insusceptive. Effects of clomipramine neonatal treatment on sexual behavior. Brain Res Dev Brain Res 2001;129:107-10.
7. Kohyama J. A quantitative assessment of the maturation of phasic motor inhibition during REM sleep. J Neurol Sci 1996;143:150-5.
8. Dreyfus-Brisac C. Sleep Ontogenesis in early human prematurity from 24 to 27 weeks. Dev Psychol 1968;1:162-169.
9. Denenberg VH, Thoman EB. Evidence for a functional role for active (REM) sleep in infancy. Sleep 1981;4:185-91.
10. Kilduff TS, Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 2000;23:359-65.
11. Thakkar MM, Ramesh V, Strecker RE et al. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol 2001;139:313-28.
12. Xi MC, Morales FR, Chase MH. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 2001;901:259-64.
13. Estabrooke IV, McCarthy MT, Ko E et al. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001;21:1656-62.
14. Peyron C, Tighe DK, van den Pol AN et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
15. Zhang JH, Sampogna S, Morales FR et al. Orexin (hypocretin)-like immunoreac-tivity in the cat hypothalamus: a light and electron microscopic study. Sleep 2001;24:67-76.
16. Lin L, Faraco J, Li R et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-76.
17. Espana RA, Baldo BA, Kelley AE et al. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001;106:699-715.
18. Hobson JA, McCarley RW, Wyzinski PW. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 1975;189:55-8.
19. McGinty DJ, Harper RM. Dorsal raphe neurons: depression of firing during sleep in cats. Brain Res 1976;101:569-75.
20. Trulson ME, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res 1979;163:135-50.
21. Aston-Jones G, Akaoka H, Charlety P et al. Serotonin selectively attenuates glu-tamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 1991;11:760-9.
22. Portas CM, Bjorvatn B, Fagerland S et al. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience 1998;83:807-14.
23. Bianco-Centurion CA, Salin-Pascual RJ. Extracellular serotonin levels in the medullary reticular formation during normal sleep and after REM sleep deprivation. Brain Res 2001;923:128-36.
24. Strecker RE, Thakkar MM, Porkka-Heiskanen T et al. Behavioral state-related changes of extracellular serotonin concentration in the pedunculopontine tegmental nucleus: a microdialysis study in freely moving animals. Sleep Res Online 1999;2:21-7.
25. Park SP, Lopez-Rodriguez F, Wilson CL et al. In vivo microdialysis measures of extracellular serotonin in the rat hippocampus during sleep-wakefulness. Brain Res 1999;833:291-6.
26. Bjorvatn B, Ursin R. Changes in sleep and wakefulness following 5-HT1A lig-ands given systemically and locally in different brain regions. Rev Neurosci 1998;9:265-73.
27. Sakai K, Crochet S. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism. Eur J Neurosci 2001;13:103-12.
28. Jacobs BL. Single unit activity of locus coeruleus neurons in behaving animals. Prog Neurobiol 1986;27:183-94.
29. Mileykovskiy BY, Kiyashchenko LI, Kodama T et al. Activation of pontine and medullary motor inhibitory regions reduces discharge in neurons located in the locus coeruleus and the anatomical equivalent of the midbrain locomotor region. J Neurosci 2000;20:8551-8.
30. Sakai K, Crochet S. Serotonergic dorsal raphe neurons cease firing by disfacilitation during paradoxical sleep. Neuroreport 2000;11:3237-41.
31. Andrade R. Regulation of membrane excitability in the central nervous system by serotonin receptor subtypes. Ann N Y Acad Sci 1998;861:190-203.
32. Blier P, Pineyro G, el Mansari M et al. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci 1998;861:204-16.
33. Graham D, Langer SZ. Advances in sodium-ion coupled biogenic amine transporters. Life Sci 1992;51:631-45.
34. Qian Y, Melikian HE, Rye DB et al. Identification and characterization of anti-depressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 1995;15:1261-74.
35. Veasey SC, Fenik P. Pharmacological Characterization of Serotonergic Receptor Activity in the Hypoglossal Nucleus. Am J Respir Crit Care Med 2002.
36. Scruggs JL, Patel S, Bubser M et al. DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J Neurosci 2000;20:8846-52.
37. Jakala P, Sirvio J, Koivisto E et al. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs. Eur J Pharmacol 1995;282:39-55.
38. Hedner T, Lundborg P. Serotoninergic development in the postnatal rat brain. J Neural Transm 1980;49:257-79.
39. Cano J, Reinoso-Suarez F. Postnatal development in the serotonin content of brain visual structures. Brain Res 1982;281:199-201.
40. Kirby ML, Mattio TG. Developmental changes in serotonin and 5-hydroxyin-doleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5, 7-dihydroxytryptamine treatment. Dev Neurosci 1982;5:394-402.
41. Uphouse LL, Bondy SC. The maturation of cortical serotonin binding sites. Brain Res 1981;227:415-7.
42. Macho L, Kvetnansky R, Culman J et al. Neurotransmitter levels in the hypothalamus during postnatal development of rats. Exp Clin Endocrinol 1986;88:142-50.
43. Rind HB, Russo AF, Whittemore SR. Developmental regulation of tryptophan hydroxylase messenger RNA expression and enzyme activity in the raphe and its target fields. Neuroscience 2000;101:665-77.
44. Feng P, Ma Y, Vogel GW. Ontogeny of REM rebound in postnatal rats. Sleep 2001;24:645-53.
45. Thakkar MM, Winston S, McCarley RW. Al receptor and adenosinergic homeo-static regulation of sleep-wakefulness: effects of antisense to the Al receptor in the cholinergic basal forebrain. J Neurosci 2003;23:4278-87.
46. Portas CM, Thakkar M, Rainnie DG et al. Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. Neuroscience 1997;79:225-35.
47. Thakkar MM, Delgiacco RA, Strecker RE et al. Adenosinergic inhibition of basal forebrain wakefulness-active neurons: a simultaneous unit recording and microdialysis study in freely behaving cats. Neuroscience 2003;122:1107-13.
48. Thakkar MM, Winston S, McCarley RW. Orexin neurons of the hypothalamus express adenosine Al receptors. Brain Res 2002;944:190-4.
49. Marks GA, ShaiTery JP, Speciale SG et al. Enhancement of rapid eye movement sleep in the rat by actions at A1 and A2a adenosine receptor subtypes with a differential sensitivity to atropine. Neuroscience 2003;116:913-20.
50. Mackiewicz M, Nikonova EV, Zimmerman JE et al. Enzymes of adenosine metabolism in the brain: diurnal rhythm and the effect of sleep deprivation. J Neurochem 2003;85:348-57.
51. Alanko L, Heiskanen S, Stenberg D et al. Adenosine kinase and 5'-nucleotidase activity after prolonged wakefulness in the cortex and the basal forebrain of rat. Neurochem Int 2003;42:449-54.
52. Porkka-Heiskanen T, Alanko L, Kalinchuk A et al. Adenosine and sleep. Sleep Med Rev 2002;6:321-32.
53. Aden U, Herlenius E, Tang LQ et al. Maternal caffeine intake has minor effects on adenosine receptor ontogeny in the rat brain. Pediatr Res 2000;48:177-83.
54. Johansson B, Georgiev V, Fredholm BB. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors. Neuroscience 1997;80:1187-207.
55. Jones SV, Barker JL, Goodman MB et al. Inositol trisphosphate mediates cloned muscarinic receptor-activated conductances in transfected mouse fibroblast A9 L cells. J Physiol 1990;421:499-519.
56. Mitani A, Ito K, Hallanger AE, Wainer BH et al. Cholinergic projections from the laterodorsal and pedunculopontine tegmental nuclei to the pontine gigantocellu-lar tegmental field in the cat. Brain Res 1988;451:397-402.
57. Semba K, Reiner PB, Fibiger HC. Single cholinergic mesopontine tegmental neurons project to both the pontine reticular formation and the thalamus in the rat. Neuroscience 1990;38:643-54.
58. Shiromani PJ, Armstrong DM, Berkowitz A et al. Distribution of choline acetyl-transferase immunoreactive somata in the feline brainstem: implications for REM sleep generation. Sleep 1988;11:1-16.
59. el Mansari M, Sakai K, Jouvet M. Unitary characteristics of presumptive cholinergic tegmental neurons during the sleep-waking cycle in freely moving cats. Exp Brain Res 1989;76:519-29.
60. Kayama Y, Ohta M, Jodo E. Firing of "possibly' cholinergic neurons in the rat laterodorsal tegmental nucleus during sleep and wakefulness. Brain Res 1992;569:210-20.
61. Buccafusco J J, Wei J, Kraft KL. The effect of the acetylcholine transport blocker vesamicol on central cholinergic pressor neurons. Synapse 1991;8:301-6.
62. Prior C, Marshall IG, Parsons SM. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter. Gen Pharmacol 1992;23:1017-22.
63. Salin-Pascual RJ, Jimenez-Anguiano A. Vesamicol, an acetylcholine uptake blocker in presynaptic vesicles, suppresses rapid eye movement (REM) sleep in the rat. Psychopharmacology (Berl) 1995;121:485-7.
64. Capece ML, Lydic R. cAMP and protein kinase A modulate cholinergic rapid eye movement sleep generation. Am J Physiol 1997;273:R1430-40.
65. Spiegel AM, Shenker A, Weinstein LS. Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr Rev 1992;13:536-65.
66. Felder CC. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. Faseb J 1995;9:619-25.
67. Homma Y, Skinner RD, Garcia-Rill E. Effects of pedunculopontine nucleus (PPN) stimulation on caudal pontine reticular formation (PnC) neurons in vitro. J Neurophysiol 2002;87:3033-47.
68. Roffwarg HP, Muzio JN, Dement WC. Development of the human sleep-dream cycle. Science 1966;152:604-619.
69. Hrdina PD, Ghosh PK, Rastogi RB et al. Ontogenic pattern of dopamine, acetylcholine, and acetylcholinesterase in the brains of normal and hypothyroid rats. Can J Physiol Pharmacol 1975;53:709-15.
70. Ninomiya Y, Koyama Y, Kayama Y. Postnatal development of choline acetyl-transferase activity in the rat laterodorsal tegmental nucleus. Neurosci Lett 2001;308:138-40.
71. Mechawar N, Watkins KC, Descarries L. Ultrastructural features of the acetylcholine innervation in the developing parietal cortex of rat. J Comp Neurol 2002;443:250-8.
72. Wall SJ, Yasuda RP, Li M, Ciesla W et al. The ontogeny of ml-m5 muscarinic receptor subtypes in rat forebrain. Brain Res Dev Brain Res 1992;66:181-5.
73. Buwalda B, de Groote L, Van der Zee EA et al. Immunocytochemical demonstration of developmental distribution of muscarinic acetylcholine receptors in rat parietal cortex. Brain Res Dev Brain Res 1995;84:185-91.
74. van Huizen F, March D, Cynader MS et al. Muscarinic receptor characteristics and regulation in rat cerebral cortex: changes during development, aging and the oestrous cycle. Eur J Neurosci 1994;6:237-43.
75. Balduini W, Cimino M, Reno F et al. Effects of postnatal or adult chronic acetylcholinesterase inhibition on muscarinic receptors, phosphoinositide turnover and ml mRNA expression. Eur J Pharmacol 1993;248:281-8.
76. Frank MG, Page J, Heller HC. The effects of REM sleep-inhibiting drugs in neonatal rats: evidence for a distinction between neonatal active sleep and REM sleep. Brain Res 1997;778:64-72.
77. Taheri S, Zeitzer JM, Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci 2002;25:283-313.
78. Gottesmann C. The neurochemistry of waking and sleeping mental activity: the disinhibition-dopamine hypothesis. Psychiatry Clin Neurosci 2002;56:345-54.
79. Lancel M, Langebartels A. Gamma-aminobutyric Acid (A) (GABA (A)) agonist 4, 5, 6, 7-tetrahydroisoxazolo[4, 5-c]pyridin-3-ol persistently increases sleep maintenance and intensity during chronic administration to rats. J Pharmacol Exp Ther 2000;293:1084-90.
80. Benington JH, Kodali SK, Heller HC. Stimulation of Al adenosine receptors mimics the electroencephalographic effects of sleep deprivation. Brain Res 1995;692:79-85.
81. Datta S. Evidence that REM sleep is controlled by the activation of brain stem pedunculopontine tegmental kainate receptor. J Neurophysiol 2002;87:1790-8.
82. Vale W, Spiess J, Rivier C et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981;213:1394-7.
83. Laatikainen TJ. Corticotropin-releasing hormone and opioid peptides in reproduction and stress. Ann Med 1991;23:489-96.
84. Rivier C, Rivest S. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol Reprod 1991;45:523-32.
85. Webster EL, Grigoriadis DE, De Souza EB. Corticotropin-releasing factor receptors in the brain-pituitary-immune axis. In: McCubbin JA, Kaufmann PJ, Nemeroff CB, eds. Neuropeptides, and Systemic Disease. San Diego: Academic Press, 1991:233-260.
86. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 1990;15:71-100.
87. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991;43:425-73.
88. Challis J, Sloboda D, Matthews S et al. Fetal hypothalamic-pituitary adrenal (HPA) development and activation as a determinant of the timing of birth, and of postnatal disease. Endocr Res 2000;26:489-504.
89. Pihoker C, Cain ST, Nemeroff CB. Postnatal development of regional binding of corticotropin-releasing factor and adenylate cyclase activity in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:581-6.
90. Avishai-Eliner S, Yi SJ, Baram TZ. Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res 1996;91:159-63.
91. Dugovic C, Maccari S, Weibel L et al. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 1999;19:8656-64.
92. Meerlo P, Koehl M, van der Borght K et al. Sleep restriction alters the hypothalamic-pituitary-adrenal response to stress. J Neuroendocrinol 2002;14:397. 402.
93. Hairston IS, Ruby NF, Brooke S et al. Sleep deprivation elevates plasma corticosterone levels in neonatal rats. Neurosci Lett 2001;315:29-32.
94. Vogel G, Neill D, Kors D, Hagler M. REM sleep abnormalities in a new animal model of endogenous depression. Neurosci Biobehav Rev 1990;14:77-83.
95. Prathiba J, Kumar KB, Karanth KS. Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression. J Neural Transm 1998;105:1335-9.
96. Arborelius L, Owens MJ, Plotsky PM et al. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999;160:1-12.
97. Riemann D, Berger M. The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. Acta Psychiatr Scand 1990;81:24-31.
98. Marrosu F, Gessa GL, Giagheddu M et al. Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res 1990;515:315-8.
99. Gonzalez MM, Valatx JL. Involvement of stress in the sleep rebound mechanism induced by sleep deprivation in the rat: use of alpha-helical CRH (9-41). Behav Pharmacol 1998;9:655-62.
100. Ohgushi A, Bungo T, Shimojo M et al. Relationships between feeding and locomotion behaviors after central administration of CRF in chicks. Physiol Behav 2001;72:287-9.
101. Clements S, Schreck CB, Larsen DA et al. Central administration of corticotropin-releasing hormone stimulates locomotor activity in juvenile chinook salmon (Oncorhynchus tshawytscha). Gen Comp Endocrinol 2002;125:319-27.
102. Opp MR. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv Neuroimmunol 1995;5:127-43.
103. Ordyan NE, Pivina SG, Rakitskaya VY et al. The neonatal glucocorticoid treatment-produced long-term changes of the pituitary-adrenal function and brain corticosteroid receptors in rats. Steroids 2001;66:883-8.
104. Levine S. Primary social relationships influence the development of the hypothalamic-pituitary-adrenal axis in the rat. Physiol Behav 2001;73:255-60.
105. Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49:391-404.